Connect Biopharma Holdings (CNTB)
(Delayed Data from NSDQ)
$1.45 USD
+0.04 (2.96%)
Updated Oct 2, 2024 03:59 PM ET
After-Market: $1.50 +0.05 (3.33%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.45 USD
+0.04 (2.96%)
Updated Oct 2, 2024 03:59 PM ET
After-Market: $1.50 +0.05 (3.33%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum F VGM
Zacks News
Are Medical Stocks Lagging Bausch Health (BHC) This Year?
by Zacks Equity Research
Here is how Bausch Health (BHC) and Connect Biopharma Holdings Limited Sponsored ADR (CNTB) have performed compared to their sector so far this year.
Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Connect Biopharma Holdings Limited Sponsored ADR (CNTB) and DexCom (DXCM) have performed compared to their sector so far this year.
Is Connect Biopharma Holdings (CNTB) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Connect Biopharma Holdings Limited Sponsored ADR (CNTB) and CRISPR Therapeutics AG (CRSP) have performed compared to their sector so far this year.
Has Connect Biopharma Holdings (CNTB) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Connect Biopharma Holdings Limited Sponsored ADR (CNTB) and Haemonetics (HAE) have performed compared to their sector so far this year.
Connect Biopharma Holdings Limited Sponsored ADR (CNTB) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Connect Biopharma Holdings Limited Sponsored ADR (CNTB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
All You Need to Know About Connect Biopharma Holdings Limited Sponsored ADR (CNTB) Rating Upgrade to Buy
by Zacks Equity Research
Connect Biopharma Holdings Limited Sponsored ADR (CNTB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).